PPARA and cardiomyopathy: In diabetic hearts, glucose oxidation is inhibited and there is decreased activation of PI3K-Akt signaling in response to insulin, while fatty acid oxidation is enhanced through increased circulating levels of free fatty acids as well as the aberrant action of PPARα, changes contributing to the development of a diabetes associated cardiomyopathy [20, 21].